PATENT CLAIM ANALYSIS

Application Number: 15979041
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "402000"]

Abstract:
The present invention describes methods and compositions for improving the therapeutic efficacy of therapeutic agents previously limited by suboptimal therapeutic performance by either improving efficacy as monotherapy or reducing side effects. Such methods and compositions are particularly applicable to bisantrene or derivatives, analogs, or prodrugs thereof.

Claim (Index 11):
The method of  claim 10  wherein the drug therapy comprises the administration of bisantrene and wherein the other indication is selected from the group consisting of:\n (a) use as an anti-infective agent; \n (b) use as an antiviral agent; \n (c) use as an antibacterial agent; \n (d) use for control of pleural effusions; \n (e) use as an antifungal agent; \n (f) use as an antiparasitic agent; \n (g) use for treatment of eczema; \n (h) use for treatment of shingles; \n (i) use for treatment of condylomata; \n (j) use for treatment of human papilloma virus (HPV); and \n (k) use for treatment of herpes simplex virus (HSV).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 93.0
- Lexical Diversity: 1.31579
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14907728', '14907729', '13817096', '14753911', '14245738']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7895936322768765
- 35 USC 102 Novelty (BERT): 0.5343433477243189
- Combined Prediction Score: 0.7640686038216208
- Mean Citation Score: 267.787678
- Max Citation Score: 348.62634
- Similarity Product: 238.8366184583187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test